Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s ...

Two office buildings in Collegeville have sold to Audubon-based Globus Medical for $6.2 million, marking an 81 percent drop ...

Looking ahead to 2025, Globus Medical has provided guidance that reflects both its standalone operations and the impact of its recent acquisition of Nevro Corp (NYSE:NVRO). The company expects net ...

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with ...

NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED). Such investors are ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports.

That's one way that travel insurance can be a lifesaver: A good policy will cover your doctor's bills, hospital stay, prescriptions and even medical evacuation if you need to be flown somewhere ...

Globus Medical has a lower P/E than the aggregate P/E of 55.32 of the Health Care Equipment & Supplies industry. Ideally, one might believe that the stock might perform worse than its peers ...